To further evaluate a potential mitigating factor associated with diabetes, the investigators negated the involvement of hyperglycemia upon altering HIF-1α activity by reducing circulating blood glucose levels with the administration of exogenous insulin. The gene discussed is INS; the disease is diabetes mellitus.